TAI · 6782.TW
Visco Vision Inc.
NT$264.00-NT$5.00 (-1.86%)
Visco Vision Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.0% below the high.
Loading market information…
TAI · 4771.TW · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Vizionfocus Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.19% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Vizionfocus Inc.’s forward annual dividend is NT$6.97 per share, paid annual. The forward yield is 3.32% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Vizionfocus Inc.’s next earnings report is currently expected on Nov 6, 2026, with estimated earnings per share of NT$4.46. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Vizionfocus Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 2011 and based in Miaoli, Taiwan, Vizionfocus Inc. operates as a manufacturer of various sophisticated products. The company primarily produces medical equipment, serving key markets across Taiwan, China, Japan, and the United States. Its manufacturing capabilities also encompass mechanical equipment, optical instruments, and precision instruments. Beyond its production activities, Vizionfocus engages in global trade and delivers consultancy services. A significant area of its business involves the full lifecycle of contact lenses, from initial research and development to design, production, and wholesale distribution.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:01 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| NT$810.54M |
| Q4 2024 | Mar 10, 2025 | NT$2.86+2.51% vs estimate | NT$761.76M |
|---|
| Q3 2024 | Nov 13, 2024 | NT$2.46-23.36% vs estimate | NT$742.00M-5.36% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$264.00-NT$5.00 (-1.86%)
Visco Vision Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.0% below the high.
NT$131.00-NT$1.50 (-1.13%)
TaiDoc Technology Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.07% below the high.
NT$56.70-NT$0.20 (-0.35%)
Standard Chem & Pharm Co. Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.36% below the high.
NT$129.50-NT$1.50 (-1.15%)
Universal Vision Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 19.57% below the high.
NT$58.20+NT$1.50 (+2.65%)
PharmaEngine, Inc.’s quoted price sits in the lower half of its reported 52-week range, 21.77% below the high.
NT$104.50-NT$3.00 (-2.79%)
Bioteque Corporation’s quoted price sits in the lower half of its reported 52-week range, 20.83% below the high.
NT$74.00-NT$3.30 (-4.27%)
Medeon Biodesign, Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.78% below the high.
NT$75.50+NT$0.20 (+0.27%)
Pacific Hospital Supply Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 15.83% below the high.
